Impaired awareness of hypoglycaemia: management and experience from Sheffield

Česká verzia

Authors: Peter Novodvorský ^1,2; Andrei Oprescu ³; Jackie Elliott ^1,3; Simon R Heller ^1,3
Authors place of work: metabolické centrum s. r. o., Trenčín ¹; Department of Oncology & Metabolism, Medical School, University of Sheffield, United Kingdom ²; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom ³
Published in the journal: Diab Obez 2020; 20(40): 93-98
Category: Reviews

Summary

Impaired awareness of hypoglycaemia (IAH) is a serious complication of type 1 diabetes which increases the risk of severe hypoglycaemia approximately sixfold, leads to impaired quality of life and increases morbidity and mortality of those affected. It is caused by impaired hormonal and symptomatic responses to hypoglycaemia as a consequence of recurrent hypoglycemic episodes. From clinical perspective it’s important that IAH is a potentially reversible condition by strict avoidance of hypoglycaemia for a period of time. In this work we briefly summarize the interventions aimed at restoration of the awareness of hypoglycaemia and present data from the IAH clinic run in the Northern General Hospital in Sheffield, UK in a form of a clinical audit covering the period of 24 months from October 2015 to September 2017.

Keywords:

clinical audit – hypoglycaemia – IAH – impaired awareness of hypoglycaemia – severe hypoglycaemia

Zdroje

Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest 2007; 117(4): 868–870. Dostupné z DOI: <http://dx.doi.org/10.1172/JCI31669>.
Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes 1991; 40(2): 223–226. Dostupné z DOI: <http://dx.doi.org/10.2337/diab.40.2.223>.
Geddes J, Schopman JE, Zammitt NN et al. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008; 25(4): 501–504. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1464–5491.2008.02413.x>.
Gold AE, MacLeod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care 1994; 17(7): 697–703. Dostupné z DOI: <http://dx.doi.org/10.2337/diacare.17.7.697>.
Clarke WL, Cox DJ, Gonder-Frederick LA et al. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 1995; 18(4): 517–522. Dostupné z DOI: <http://dx.doi.org/10.2337/diacare.18.4.517>.
Geddes J, Wright RJ, Zammitt NN et al. An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care 2007; 30(7): 1868–1870. Dostupné z DOI: <http://dx.doi.org/10.2337/dc06–2556>.
Novodvorsky P, Bernjak A, Chow E et al. Diurnal Differences in Risk of Cardiac Arrhythmias During Spontaneous Hypoglycemia in Young People With Type 1 Diabetes. Diabetes Care 2017; 40(5): 655–662. Dostupné z DOI: <http://dx.doi.org/10.2337/dc16–2177>.
Yeoh E, Choudhary P, Nwokolo M et al. Interventions That Restore Awareness of Hypoglycemia in Adults With Type 1 Diabetes: A Systematic Review and Meta-analysis. Diabetes Care 2015; 38(8): 1592–1560. Dostupné z DOI: 9. <http://dx.doi.org/10.2337/dc15–0102>.
Choudhary P, Rickels MR, Senior PA et al. Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia. Diabetes Care 2015; 38(6): 1016–1029. Dostupné z DOI: <http://dx.doi.org/10.2337/dc15–0090>.
Hopkins D, Lawrence I, Mansell P et al. Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience. Diabetes Care. 2012; 35(8): 1638–1642. Dostupné z DOI: <http://dx.doi.org/10.2337/dc11–1579>.
Muhlhauser I, Jorgens V, Berger M et al. Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia 1983; 25(6): 470–476. Dostupné z DOI: <http://dx.doi.org/10.1007/BF00284453>.
Bott S, Bott U, Berger M et al. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 1997; 40(8): 926–932. Dostupné z DOI: <http://dx.doi.org/10.1007/s001250050769>.
Cox D, Gonder-Frederick L, Polonsky W et al. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care 1995; 18(4): 523–538. Dostupné z DOI: <http://dx.doi.org/10.2337/diacare.18.4.523>.
de Zoysa N, Rogers H, Stadler M et al. A psychoeducational program to restore hypoglycemia awareness: the DAFNE-HART pilot study. Diabetes Care 2014; 37(3): 863–866. Dostupné z DOI: <http://dx.doi.org/10.2337/dc13–1245>.
Cranston I, Lomas J, Maran A et al. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet 1994; 344(8918): 283–287. Dostupné z DOI: <http://dx.doi.org/10.1016/s0140–6736(94)91336–6>.
Little SA, Leelarathna L, Walkinshaw E et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 x 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014; 37(8): 2114–2122. Dostupné z DOI: <http://dx.doi.org/10.2337/dc14–0030>.
Bergenstal RM, Garg S, Weinzimer SA et al. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients with Type 1 Diabetes. JAMA 2016; 316(13): 1407–1408. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2016.11708>.
Brown SA, Kovatchev BP, Raghinaru D et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med 2019; 381(18): 1707–1717. Dostupné z DOI: <http://dx.doi.org//10.1056/NEJMoa1907863>.